Home
NewsNewsognosos today announced its acquisition of Cox Prosight, an award-winning, real-time location service (RTLS) platform purpose-built for hospitals
The acquisition of Cox Prosight by Cognosos comes at a critical time when hospitals are grappling with significant challenges to improve operational efficiency, address labor shortages and improve patient experience.
“Today is a significant milestone in Cognosos’ journey,” said Braxton Jarratt, CEO of Cognosos. “Over the last several years, both companies have made massive, complementary investments to provide critical visibility, efficiency and safety to healthcare workers and patients. The integration of these two like-minded technology platforms reinforces our commitment to equipping hospitals with the tools they need to fulfill their mission to provide outstanding care to patients.”
Cox Prosight has developed a modern, extensible platform that integrates with multiple hardware vendors. Known for its strong analytics and reporting capabilities, the company has a reputation for delivering solutions that meet the complex demands of the healthcare environment.
George Valentine, AVP, GM of Cox Prosight, added, “The Cox Prosight team has dedicated years to developing the absolute best software platform that meets the evolving needs of hospitals. Our mission continues with Cognosos–a company that shares our passion for delivering transformative solutions to healthcare providers.”
The integrated solution from Cognosos and Cox Prosight will directly address the increasing challenges in the healthcare industry. By combining both systems into a future-proof, cost-effective and highly extensible cloud-based platform, RTLS will be more accessible to hospitals of all sizes. This solution will help administrators make data-driven decisions to address the developing needs of hospitals and amplify patient care.
Adrian Jennings, Chief Product Officer at Cognosos, “The addition of Cox Prosight expands our platform and accelerates our vision of providing healthcare systems with the tools needed to address critical operational challenges. Additionally, we’re excited about its ability to run across multiple hardware providers which instantly expands our portfolio of supported devices. With our combined resources, important new product offerings and functionality are planned for release in the coming months.”
Cognosos’ LocationAI®, the AI-native location intelligence technology revolutionized the RTLS market by offering room-level accuracy without the need for in-room infrastructure, functioning seamlessly across campus environments, both indoors and outdoors. Used by hospitals across the US–as well as over half of the top automotive manufacturers in North America–Cognosos helps organizations identify operational and safety issues to save time, reduce shrinkage and uncover bottlenecks.https://www.youtube.com/watch?v=guiihD9JxE8
For the first time, the World Health Organization has officially listed the Ministry of Health, Labor, and Welfare/Pharmaceuticals and Medical Devices Agency (MHLW/PMDA) of Japan, Health Canada, and the Medicines and Healthcare Products Regulatory Agency (MHRA) of the UK as the new WHO-listed authorities (WLAs), a status that is granted to national authorities that meet the highest international regulatory benchmarks when it comes to medical products.
Fertility is a person’s ability to conceive children. In general, when a woman is unable to get pregnant even after at least one year of unprotected sex, she is considered to have infertility and her doctor will begin evaluating the possible causes.
Menopause can usher in a host of disruptive symptoms like hot flashes, night sweats and sleep problems. Hormone therapy promises relief. But many women wonder about taking it. That’s because the treatment, subject of a recent expert panel convened by the Food and Drug Administration, has long been shrouded in uncertainty.
With the partnership, PatientPoint’s waiting room and exam room screens will feature messaging that promotes MyHealthTeam’s platform, which serves over 27 million patients annually through an expanding network of more than 60 patient communities
In an age where customization is prized as well as friction is the enemy of efficiency, zero-click care – passive patient engagement by way of ambient sensing and IoT in hospitals
Explore the cost of IUI worldwide, comparing prices and factors aExplore the cost of IUI worldwide, comparing prices and factors aExplore the cost of IUI worldwide, comparing prices and factors a
Under the terms of the agreement, Exeltis will acquire exclusive rights to market and distribute Theranexus’ proprietary product across key regions, including the European Union, UK, Latin America, and selected Middle Eastern countries. This collaboration will target both Gaucher and Niemann-Pick type C diseases.
